Interferon and ribavirin combination therapy are linked to severe indirect hyperbilirubinemia in patients with nt-211G > A variant of UGT1A1 gene

Interferon and ribavirin combination therapy are linked to severe indirect hyperbilirubinemia in patients with nt-211G > A variant of UGT1A1 gene

Bibliographic Details
Main Authors:	Nyam Biziya, Sarantuya Gidaagaya, Bira Namdag, Sien-Sing Yang
Format:	Article
Language:	English
Published:	Elsevier 2015-11-01
Series:	Journal of the Formosan Medical Association
Online Access:	http://www.sciencedirect.com/science/article/pii/S092966461500025X

Similar Items

211 G to A variation of UGT1A1 and severe neonatal hyperbilirubinemia
by: Yu-Jung Lin, et al.
Published: (2018-02-01)

Association of UGT1A1 variants and hyperbilirubinemia in breast-fed full-term Chinese infants.
by: Youyou Zhou, et al.
Published: (2014-01-01)

Profiling of UGT1A1*6, UGT1A1*60, UGT1A1*93, and UGT1A1*28 Polymorphisms in Indonesian Neonates With Hyperbilirubinemia Using Multiplex PCR Sequencing
by: Radhian Amandito, et al.
Published: (2019-08-01)

Commentary: Profiling of UGT1A1*6, UGT1A1*60, UGT1A1*93, and UGT1A1*28 Polymorphisms in Indonesian Neonates With Hyperbilirubinemia Using Multiplex PCR Sequencing
by: Mohammad Reza Heydari, et al.
Published: (2020-02-01)

The effect of UGT1A1 promoter polymorphism in the development of hyperbilirubinemia and cholelithiasis in hemoglobinopathy patients.
by: Suad AlFadhli, et al.
Published: (2013-01-01)

Analysis of the UGT1A1 Genotype in Hyperbilirubinemia Patients: Differences in Allele Frequency and Distribution
by: Xiao-xiao Mi, et al.
Published: (2019-01-01)

Clinical Significance of UGT1A1 Genetic Analysis in Chinese Neonates with Severe Hyperbilirubinemia
by: Hui Yang, et al.
Published: (2016-08-01)

Combined Effects of UGT1A1 and SLCO1B1 Variants on Chinese Adult Mild Unconjugated Hyperbilirubinemia
by: Jie Bai, et al.
Published: (2019-10-01)

UGT1A1 gene and neonatal hyperbilirubinemia: a preliminary study from Bengkulu, Indonesia
by: Radhian Amandito, et al.
Published: (2018-03-01)

Hyperbilirubinemia in atazanavir treated HIV-infected patients: the impact of the UGT1A1*28 allele
by: Panagopoulos P, et al.
Published: (2017-06-01)

UGT1A1 Genetic Variations and a Haplotype Associated with Neonatal Hyperbilirubinemia in Indonesian Population
by: Dewi A. Wisnumurti, et al.
Published: (2018-01-01)

The role of UGT1A1 (c.-3279 T > G) gene polymorphisms in neonatal hyperbilirubinemia susceptibility
by: Zijin Li, et al.
Published: (2020-11-01)

Investigating Whether Screening or Testing for the Variation Status of UGT 1A1 Gene is Helpful in Managing Neonatal Hyperbilirubinemia
by: Yao-Jong Yang
Published: (2020-10-01)

A novel UGT1A1 gene mutation causing severe unconjugated hyperbilirubinemia: a case report
by: Xiaoxia Shi, et al.
Published: (2019-05-01)

Hyperbilirubinemia in atazanavir-treated human immunodeficiency virus-infected patients: the impact of the UGT1A1*28 allele
by: Naidoo A, et al.
Published: (2017-08-01)

UGT1A1 mutation association with increased bilirubin levels and severity of unconjugated hyperbilirubinemia in ABO incompatible newborns of China
by: Hui Yang, et al.
Published: (2021-06-01)

Acute rhabdomyolysis and chylous ascites in a patient with cirrhosis and malignant hepatic tumor
by: Sarantuya Gidaagaya, et al.
Published: (2014-02-01)

Developmental outcome of severe neonatal indirect hyperbilirubinemia
by: Manizheh Mostafa Gharehbaghi, et al.
Published: (2021-01-01)

Serum Zinc Level in Neonates with Indirect Hyperbilirubinemia
by: Saeda Ali, et al.
Published: (2020-01-01)

The effect of phototherapy on oxidative stress in newborns with indirect hyperbilirubinemia
by: Emel Torun, et al.
Published: (2013-01-01)

Effectiveness of single and double phototherapy on indirect hyperbilirubinemia in neonates
by: Nanda Susanti Milyana, et al.
Published: (2011-12-01)

INDIRECT HYPERBILIRUBINEMIA OF THE CHILD AGE AS A CONSEQUENCE OF SPHEROCYTOSIS
by: Gordana Kostic, et al.
Published: (2000-05-01)

Editorial 21.1
by: Silvia Maria Cintra da Silva, et al.

Créditos 21.1
by: Créditos 21.1
Published: (2014-03-01)

Efficacy and safety of triple therapy with recombinant interleukin-1β, recombinant interferon-α and ribavirin in patients with chronic hepatitis C, genotype 1 infection, the non-responders to previous treatment with interferon and ribavirin
by: Yu. V. Lobzin, et al.
Published: (2014-09-01)

Retreatment of hepatitis C patients with pegylated interferon combined with ribavirin in non-responders to interferon plus ribavirin. Is it different in real life?
by: Gonçales Neiva SL, et al.
Published: (2010-07-01)

Increase of ribavirin dose improves sustained virological response in HCV-genotype 1 patients with a partial response to peg-interferon and ribavirin
by: Fabio Conti, et al.
Published: (2014-03-01)

Role of microRNA modulation in the interferon-α/ribavirin suppression of HIV-1 in vivo.
by: Mohamed Abdel-Mohsen, et al.
Published: (2014-01-01)

Cranial Magnetic Resonance Imaging Findings in Patients with Indirect Hyperbilirubinemia
by: Esra Meltem Kayahan Ulu, et al.
Published: (2012-06-01)

Prevalence of Gilbert syndrome in parents of neonates with pathologic indirect hyperbilirubinemia
by: Saki Forough, et al.
Published: (2011-01-01)

Neonatal indirect hyperbilirubinemia and glucose-6-phosphate dehydrogenase deficiency
by: Hasan M. Isa, et al.
Published: (2017-04-01)

Comparison study between the treatment of Hepatitis C virus with (peg-interferon, ribavirin, silymarin) and (peg-interferon, ribavirin) in Baghdad teaching hospital.
by: Khalid A. Al-Khazraji
Published: (2017-04-01)

Effects of Host and virus related factors on Interferon-α+ribavirin and Pegylated-interferon+ribavirin treatment outcomes in Chronic Hepatitis C patients
by: Saleem Sana, et al.
Published: (2011-05-01)

Characteristics of hepatitis C treatment with pegylated interferons and ribavirin
by: Ricardo Jiménez-Méndez, et al.
Published: (2010-01-01)

The Evaluation of Genetic Profiles of UGT1A4 and UGT1A6 in the Turkish Population
by: Zuhal Uçkun Şahinoğulları
Published: (2021-03-01)

Correlation between serum vitamin D level and neonatal indirect hyperbilirubinemia
by: Shahrokh Mehrpisheh, et al.
Published: (2018-05-01)

Epigenetics and microRNAs in UGT1As
by: Cui-Lan Meng, et al.
Published: (2021-05-01)

Understanding the impact of 1q21.1 copy number variant
by: Harvard Chansonette, et al.
Published: (2011-08-01)

The polymorphisms of UGT1A7 and UGT1A10 among Taiwan lung cancer patients.
by: LEE, YU-CHING, et al.
Published: (2005)

Drug serum levels and genetic polymorphisms of UGT1A3, UGT1A4, UGT2B7 and HLA involved in lamotrigine hypersensitivity.
by: Chun-Yi Wu, et al.
Published: (2010)

Cannot write session to /tmp/vufind_sessions/sess_p0uhkrt7qu6f7203vtotq6tj5e